期刊文献+

降钙素原对老年慢性阻塞性肺疾病急性加重合并肺炎的预测价值 被引量:5

Predictive value of procalcitonin on acute exacerbation of chronic obstructive pulmonary disease combined with pneumonia in the elderly patients
原文传递
导出
摘要 目的探讨降钙素原(PCT)在预测老年慢性阻塞性肺疾病急性加重(AECOPD)合并肺炎患者中的价值。方法选取2012年10月至2014年5月住院的160例老年AECOPD患者,根据影像学结果分为单纯AECOPD组73例,AECOPD合并肺炎组87例,记录2组间性别、年龄、吸烟情况、既往咳痰喘病史、此次急性加重病程、入院前抗生素应用时间、吸烟指数等一般情况,入院24 h内测定PCT、C-反应蛋白(CRP)、白细胞计数(WBC)及中性粒细胞百分比(NE%)并进行比较。对2组间差异有统计学意义的指标进行Logistic回归分析。对Logistic回归有意义的指标绘制受试者工作特征(ROC)曲线,计算曲线下面积(AUC)。结果2组间既往咳痰喘病史、PCT、CRP、WBC、NE%差异有统计学意义(P〈0.05)。对上述5项指标行Logistic回归分析,发现仅PCT(P=0.002)有预测意义。PCT预测老年AECOPD患者合并肺炎的ROC曲线下面积为0.878(95%CI:0.823-0.933)。根据ROC曲线选取最佳截点为0.075 ng/ml,预测老年AECOPD患者合并肺炎的灵敏度为83.9%,特异度为79.5%。结论血清PCT可以作为判断老年AECOPD患者是否合并肺炎的辅助检查指标。 Objective To explore the predictive value of procalcitonin(PCT) on acute exacerbation of chronic obstructive pulmonary disease(AECOPD) combined with a concomitant pneumonia in the elderly patients.Methods 160 elderly AECOPD patients,hospitalized from October 2012 to May 2014,were divided into AECOPD group(73 patients)and AECOPD combined with pneumonia group(87 patients) according to result of imaging data.Gender,age,smoking status,history of coughing,acute exacerbation course,application of antibiotics prior to admission time,smoking index were recorded.The serum levels of PCT,C-reactive protein(CRP),white blood cell(WBC),and neutrophil percentage(NE%) were measured within 24 hours after admission and compared between two groups.Logistic regression,the receiver-operating characteristic(ROC) cun'e and the area under the cun'e(AUC) were analyzed for statistically significant indicators between two groups.Results The history of coughing,PCT,CRP,WBC,and NE%levels in AECOPD combined with pneumonia group were significantly higher than AECOPD group(P〈0.05).Logistic regression showed that only PCT was a significant predictor of pneumonia(P = 0.002).The AUC of PCT predicting the combination of pneumonia in elderly patients with AECOPD was 0.878(95%CI:0.823-0.933).Using a cut-off point of 0.075 ng/ml for PCT,the sensitivitiy and specificitiy for pneumonia in elderly patients with AECOPD were 83.9%and 79.5%respectively.Conclusions Serum procalcitonin measurements in elderly patients with AECOPD plays a role in the diagnosis of pneumonia.
出处 《实用老年医学》 CAS 2015年第8期628-631,共4页 Practical Geriatrics
关键词 降钙素原 慢性阻塞性肺疾病 老年人 肺炎 procalcitonin chronic obstructive pulmonary disease aged pneumonia
  • 相关文献

参考文献10

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-80. 被引量:2021
  • 2蔡柏蔷.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(草案)[J].中华哮喘杂志(电子版),2013,7(1):1-13. 被引量:192
  • 3钱小顺,侯允天,薛桥,韩亚玲,刘雪红,刘建立,王士雯.1605例老年多器官功能衰竭的临床分析[J].中华老年多器官疾病杂志,2002,1(1):7-10. 被引量:128
  • 4Rutschmann OT, Comuz J, Poletti PA, et al. Should pulmo- nary embolism be suspected in exacerbation of chronic ob- structive pulmonary disease.9 [J]. Thorax, 2007, 62 (2) : 121-125.
  • 5Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions : past, present and future [J]. BMC Med, 2011, 9:107.
  • 6Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and out- come in lower respiratory tract infections : cluster- randomised, single-blinded intervention trial [ J ]. Lancet, 2004, 363(9409) :600-607.
  • 7Wilson R, Sethi S, Anzueto A, et al. Antibiotics for treat- ment and prevention of exacerbations of chronic obstructive pulmonary disease[ J]. J Infect, 2013, 67(6) :497-515.
  • 8Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procal- citonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial[J]. JAMA, 2009, 302(10) :1059-1066.
  • 9Lacoma A, Prat C, Andrco F, et al. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease [ J ]. Int J Chron Obstruct Pulmon Dis. 2011. 6:157-169.
  • 10常春,姚婉贞,陈亚红,刘振英,张晓伟.血清降钙素原对慢性阻塞性肺疾病加重期患者下呼吸道细菌感染的诊断价值[J].北京大学学报(医学版),2006,38(4):389-392. 被引量:50

二级参考文献39

共引文献2367

同被引文献43

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8229
  • 2Cadet J. Rapid diagnostic methods in the detection of sepsis [ J ]. Infect Dis Clin North Am, 1999, 13 (2):483-494.
  • 3Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target [ J]. Br J Pharmacol, 2010,159(2) :253-264.
  • 4Endo S, Aikawa N, Fujishima S, et al. Usefulness of procaleitonin serum level for the discrimination of severe sepsis from sepsis : a muhieenter pro- spective study [ J ]. J Infect Chemother, 2008,14 ( 3 ) : 244-249.
  • 5Dellinger RP, Levy MM, Cadet JM,et al. Surviving Sepsis Campaign: in- ternational guidelines for management of severe sepsis and septic shock: 2008 [ J ]. Crit Care Med, 2008, 36 ( 1 ) : 296-327.
  • 6Nargis W, Ibrahim M, Ahamed BU, et al. Procalcitonin versus C- reactive protein: Usefulness as bio- marker of sepsis in ICU patient[ J]. Int J Crit Illn Inj Sci,2014,4(3) : 195-199.
  • 7Jolivet P, Christen G, Seematter G, et al. Usefulness of biomarkers of sepsis in the ICU [ J ]. Rev Med Su- isse, 2011, 7(321) :2430-2434.
  • 8Briel M, Christ-Crain M, Young J, et al. Procalcitonin-guided antibioticuse versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and base- line characteristics of participating general practitioners [ J ]. BMC Fam Pract, 2005,45(6) :34.
  • 9Nylen ES, Whang KT, Sinider TH, et al. Mortality is increased by procalei- tonin and decreased by an antiserum reactive to procalcitonin in experi- mental sepsis [ J ]. Crit Care Med, 1998, 26(6) : 1001-1006.
  • 10Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infec- tion[ J] .Lancet, 1993,341 (8844) :515-518.

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部